Influenza HA (307-319) – 1 mg

Overview

The Influenza HA (307-319) peptide is a crucial component in immunological research and diagnostics. This specific peptide is an HLA-DRB 0101-restricted epitope derived from the Influenza hemagglutinin, making it invaluable for studies related to influenza immunity. Researchers can utilize this peptide for various applications, including vaccine development and immune response analysis.

Key Features

• High purity peptide, ideal for immunological assays
• HLA-DRB 0101-restricted epitope ensures specificity in research
• Useful for vaccine development and immune monitoring
• Available in a convenient pack size of 1 mg
• Supports diverse applications in peptide synthesis and protein labeling

Specifications

FAQ

What is the significance of the Influenza HA (307-319) peptide?

This peptide is vital for research into the immune response to influenza, particularly in the context of HLA-DRB 0101 restriction. It helps in understanding how the immune system recognizes influenza viruses.

How should this peptide be stored?

For optimal stability, store at -20°C. Avoid repeated freeze-thaw cycles to maintain the integrity of the peptide.

Can this peptide be used in combination with other assays?

Yes, the Influenza HA (307-319) peptide can be utilized in conjunction with a variety of assays, including ELISA and flow cytometry, to enhance the understanding of immune responses.

If you’re conducting research on influenza or developing vaccines, this peptide is available for immediate purchase. Explore our other offerings in the peptides category for more tools to assist your work in immunology. Don’t forget to check out our PKG Substrate and Autocamtide-2 for additional assays. Order today to enhance your research capabilities!

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled